New drug VS-01 tested for severe liver failure – study halted early
NCT ID NCT05900050
First seen Sep 30, 2025 · Last updated May 25, 2026 · Updated 24 times
Summary
This study tested a drug called VS-01 in 15 adults with acute-on-chronic liver failure (sudden worsening of long-term liver disease) and fluid in the belly. The goal was to see if VS-01, given into the abdomen, improves liver function and survival when added to standard care. The study was stopped early, so results are limited.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE-ON-CHRONIC LIVER FAILURE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
ASST Grande Ospedale Metropolitano Niguarda
Milan, 20162, Italy
-
Azienda Ospedaliero-Universitaria Policlinico Umberto I
Roma, 00185, Italy
-
Baylor Clinic
Houston, Texas, 77030, United States
-
CHU Rennes - Hôpital Pontchaillou
Rennes, 35033, France
-
Centre Hospitalier Régional Universitaire de Tours
Chambray-lès-Tours, 37170, France
-
Charité Universitätsmedizin Berlin
Berlin, State of Berlin, 13353, Germany
-
Cleveland Clinic
Cleveland, Ohio, 44195, United States
-
Columbia University Medical Center/ New York Presbyterian Hospital
New York, New York, 10032, United States
-
Debreceni Egyetem Klinikai Központ
Debrecen, 4032, Hungary
-
Heves Vármegyei Markhot Ferenc Oktatókórház és Rendelőintézet
Eger, 3300, Hungary
-
Hospital Clínic de Barcelona
Barcelona, Barcelona, 08036, Spain
-
Hôpital Universitaire Pitié Salpêtrière
Paris, 75013, France
-
Hôpital de la Croix Rousse
Lyon, 69004, France
-
Mayo Clinic
Rochester, Minnesota, 55905, United States
-
Medical University of South Carolina
Charleston, South Carolina, 29425, United States
-
Medizinische Hochschule Hannover
Hanover, 30625, Germany
-
Medstar Georgetown University Hospital
Washington D.C., District of Columbia, 20007, United States
-
Piedmont Atlanta Hospital
Atlanta, Georgia, 30309, United States
-
Richmond VA Medical Center
Richmond, Virginia, 23249, United States
-
Tampa General Hospital
Tampa, Florida, 33606, United States
-
The Liver Institute at Methodist Dallas
Dallas, Texas, 75203, United States
-
Universitair Ziekenhuis Antwerpen
Edegem, 2650, Belgium
-
Universitatsklinikum Munster
Münster, North Rhine-Westphalia, 48149, Germany
-
University of California Davis Medical Center
Sacramento, California, 95817, United States
-
University of Missouri Health Care
Columbia, Missouri, 65212, United States
-
Virginia Commonwealth University
Richmond, Virginia, 23298, United States
Conditions
Explore the condition pages connected to this study.